Surgical laparoscopy, endoscopy & percutaneous techniques
-
Surg Laparosc Endosc Percutan Tech · Oct 2014
Randomized Controlled TrialSugammadex reduces postoperative pain after laparoscopic bariatric surgery: a randomized trial.
Morbid obese (MO) population is increasing every year worldwide, and laparoscopic bariatric surgery (LBS) has a central role in their treatment. The postoperative period of MO is not free from complications. The introduction of sugammadex has brought huge developments in patient's safety and nowadays LBS is performed with better care and quality. However, the effect of this agent in postoperative pain is still unknown. ⋯ Sugammadex is associated with less pain felt in the PACU. This "opioid-sparing" effect, combined with less PONV and a faster discharge from the PACU, makes sugammadex an indispensable drug in this type of patients and allows fast-track surgery in the MO.